Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review

Courtney Crawford1, Colby Fernelius2, Paula Young1, Stephen Groo2, Darryl Ainbinder21Blanchfield Army Hospital, Fort Campbell, KY, USA; 2Madigan Army Medical Center, Fort Lewis, WA, USAContext: The purpose of this study was to conduct a quality improvement (QI), applied practical review of the Ameri...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Crawford CM, Fernelius CA, Young PE, Groo SC, Ainbinder DJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/7de728c2bb894db18307c35736e47de3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7de728c2bb894db18307c35736e47de3
record_format	dspace
spelling	oai:doaj.org-article:7de728c2bb894db18307c35736e47de32021-12-02T00:53:05ZApplication of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review1177-54671177-5483https://doaj.org/article/7de728c2bb894db18307c35736e47de32011-11-01T00:00:00Zhttp://www.dovepress.com/application-of-the-ajcc-7th-edition-carcinoma-of-the-eyelid-staging-sy-a8694https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Courtney Crawford1, Colby Fernelius2, Paula Young1, Stephen Groo2, Darryl Ainbinder21Blanchfield Army Hospital, Fort Campbell, KY, USA; 2Madigan Army Medical Center, Fort Lewis, WA, USAContext: The purpose of this study was to conduct a quality improvement (QI), applied practical review of the American Joint Committee on Cancer (AJCC) 7th edition, Carcinoma of the Eyelid staging system. AJCC utilizes a primary tumor, lymph node, metastasis (pTNM) cancer staging approach.Objective: We wanted to determine if the AJCC pTNM carcinoma staging system identified patients with highly aggressive carcinoma of the eyelid. We also wanted to determine if there were any unexpected issues in its practical application. Design: We conducted a 15-year, consecutive, retrospective review of all cases of excisional biopsy for carcinoma of the eyelid. We reviewed the original histopathology slides and complete pathology records for each case.Results: Over a 15-year review period, 52 cases of excisional biopsy for carcinoma of the eyelid were identified. The average age of the study population was 72 years. Nodular well-differentiated basal cell carcinoma (BCC) was the predominant histology for 85% of cases. Morpheaform/metatypical BCC was the next dominant at 9%. Squamous cell carcinoma and sebaceous carcinoma followed at 4% and 2%, respectively. We were able to assign clear staging to 50 of the 52 cases with the available pathology data. The stage results were as follows: stage 1A 72%, stage 1B 22%, stage II 4%, stage III 2%, with no cases of stage IV metastatic disease.Conclusions: The 7th edition AJCC Carcinoma of the Eyelid chapter proved to be a practical tool for carcinoma staging of the eyelid. The largest tumor dimension remains an effective predictive factor. High-grade pathologic prognostic factors such as tumor necrosis or perineural spread had a 100% association with a final stage of II or greater. Concordance and compliance was 100% for the recommended site-specific pathologic risk factors. Regarding squamous cell carcinoma of the eyelid, three new required data points had a 0% reporting rate over 15 years. Overall, smaller less invasive tumors were classified as stage 1A and 1B tumors. More invasive and higher risk tumors fell into appropriate higher staging classifications. The newly recommended prognostic site-specific tumor factors appear to work well with a high concordance with staging severity, and strong medical community acceptance.Keywords: eyelid, pathology, oncologyCrawford CMFernelius CAYoung PEGroo SCAinbinder DJDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 1645-1648 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Crawford CM Fernelius CA Young PE Groo SC Ainbinder DJ Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review
description	Courtney Crawford1, Colby Fernelius2, Paula Young1, Stephen Groo2, Darryl Ainbinder21Blanchfield Army Hospital, Fort Campbell, KY, USA; 2Madigan Army Medical Center, Fort Lewis, WA, USAContext: The purpose of this study was to conduct a quality improvement (QI), applied practical review of the American Joint Committee on Cancer (AJCC) 7th edition, Carcinoma of the Eyelid staging system. AJCC utilizes a primary tumor, lymph node, metastasis (pTNM) cancer staging approach.Objective: We wanted to determine if the AJCC pTNM carcinoma staging system identified patients with highly aggressive carcinoma of the eyelid. We also wanted to determine if there were any unexpected issues in its practical application. Design: We conducted a 15-year, consecutive, retrospective review of all cases of excisional biopsy for carcinoma of the eyelid. We reviewed the original histopathology slides and complete pathology records for each case.Results: Over a 15-year review period, 52 cases of excisional biopsy for carcinoma of the eyelid were identified. The average age of the study population was 72 years. Nodular well-differentiated basal cell carcinoma (BCC) was the predominant histology for 85% of cases. Morpheaform/metatypical BCC was the next dominant at 9%. Squamous cell carcinoma and sebaceous carcinoma followed at 4% and 2%, respectively. We were able to assign clear staging to 50 of the 52 cases with the available pathology data. The stage results were as follows: stage 1A 72%, stage 1B 22%, stage II 4%, stage III 2%, with no cases of stage IV metastatic disease.Conclusions: The 7th edition AJCC Carcinoma of the Eyelid chapter proved to be a practical tool for carcinoma staging of the eyelid. The largest tumor dimension remains an effective predictive factor. High-grade pathologic prognostic factors such as tumor necrosis or perineural spread had a 100% association with a final stage of II or greater. Concordance and compliance was 100% for the recommended site-specific pathologic risk factors. Regarding squamous cell carcinoma of the eyelid, three new required data points had a 0% reporting rate over 15 years. Overall, smaller less invasive tumors were classified as stage 1A and 1B tumors. More invasive and higher risk tumors fell into appropriate higher staging classifications. The newly recommended prognostic site-specific tumor factors appear to work well with a high concordance with staging severity, and strong medical community acceptance.Keywords: eyelid, pathology, oncology
format	article
author	Crawford CM Fernelius CA Young PE Groo SC Ainbinder DJ
author_facet	Crawford CM Fernelius CA Young PE Groo SC Ainbinder DJ
author_sort	Crawford CM
title	Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review
title_short	Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review
title_full	Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review
title_fullStr	Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review
title_full_unstemmed	Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review
title_sort	application of the ajcc 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/7de728c2bb894db18307c35736e47de3
work_keys_str_mv	AT crawfordcm applicationoftheajcc7theditioncarcinomaoftheeyelidstagingsystemamedicalcenterpathologybased15yearreview AT ferneliusca applicationoftheajcc7theditioncarcinomaoftheeyelidstagingsystemamedicalcenterpathologybased15yearreview AT youngpe applicationoftheajcc7theditioncarcinomaoftheeyelidstagingsystemamedicalcenterpathologybased15yearreview AT groosc applicationoftheajcc7theditioncarcinomaoftheeyelidstagingsystemamedicalcenterpathologybased15yearreview AT ainbinderdj applicationoftheajcc7theditioncarcinomaoftheeyelidstagingsystemamedicalcenterpathologybased15yearreview
_version_	1718403448756502528

Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review

Ejemplares similares